APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contract Pharmaceutical Manufacturing

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Selected research

Market Outlook & Growth Opportunities

Global Contract Pharmaceutical Manufacturing Market Outlook and Growth Opportunities 2026

21 December 2025206 pages

Choose your research edition.

Industry ResearchContract Pharmaceutical Manufacturing Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Contract Pharmaceutical Manufacturing Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Contract Pharmaceutical Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contract Pharmaceutical Manufacturing Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Contract Pharmaceutical Manufacturing Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%.

North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent.

Read the full market overview

In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise.

This report provides an overview of the global Contract Pharmaceutical Manufacturing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Contract Pharmaceutical Manufacturing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Contract Pharmaceutical Manufacturing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Contract Pharmaceutical Manufacturing market.

Contract Pharmaceutical Manufacturing Segment by Company

Catalent

DPx

Lonza

Piramal Healthcare

Aenova

Jubilant

Famar

Boehringer Ingelheim

Fareva Holding

AbbVie

Nipro Corp

Vetter

Sopharma

DPT Laboratories

Recipharm

NextPharma

Dishman

Aesica

Contract Pharmaceutical Manufacturing Segment by Type

Oral

Injectable

API

Other

Contract Pharmaceutical Manufacturing Segment by Application

Large Enterprise

Small Medium Enterprise

Contract Pharmaceutical Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Contract Pharmaceutical Manufacturing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Contract Pharmaceutical Manufacturing key companies, revenue, market share, and recent developments.

3. To split the Contract Pharmaceutical Manufacturing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Contract Pharmaceutical Manufacturing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Contract Pharmaceutical Manufacturing significant trends, drivers, influence factors in global and regions.

6. To analyze Contract Pharmaceutical Manufacturing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contract Pharmaceutical Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contract Pharmaceutical Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contract Pharmaceutical Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Contract Pharmaceutical Manufacturing industry.

Chapter 3: Detailed analysis of Contract Pharmaceutical Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Contract Pharmaceutical Manufacturing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Contract Pharmaceutical Manufacturing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Contract Pharmaceutical Manufacturing Industry Trends Table 2. Contract Pharmaceutical Manufacturing Industry Drivers Table 3. Contract Pharmaceutical Manufacturing Industry Opportunities and Challenges Table 4. Contract Pharmaceutical Manufacturing Industry Restraints Table 5. Global Contract Pharmaceutical Manufacturing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Contract Pharmaceutical Manufacturing Revenue Share by Company (2021-2026) Table 7. Global Contract Pharmaceutical Manufacturing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Contract Pharmaceutical Manufacturing Key Company Manufacturing Base & Headquarters Table 9. Global Contract Pharmaceutical Manufacturing Company, Product Type & Application Table 10. Global Contract Pharmaceutical Manufacturing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Contract Pharmaceutical Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Oral Table 15. Significant Companies of Injectable Table 16. Significant Companies of API Table 17. Significant Companies of Other Table 18. Global Contract Pharmaceutical Manufacturing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Contract Pharmaceutical Manufacturing Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Contract Pharmaceutical Manufacturing Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Contract Pharmaceutical Manufacturing Sales Value Share by Type (2021-2026) Table 22. Global Contract Pharmaceutical Manufacturing Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Large Enterprise Table 24. Significant Companies of Small Medium Enterprise Table 25. Global Contract Pharmaceutical Manufacturing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Contract Pharmaceutical Manufacturing Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Contract Pharmaceutical Manufacturing Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Contract Pharmaceutical Manufacturing Sales Value Share by Application (2021-2026) Table 29. Global Contract Pharmaceutical Manufacturing Sales Value Share by Application (2027-2032) Table 30. Global Contract Pharmaceutical Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Contract Pharmaceutical Manufacturing Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Contract Pharmaceutical Manufacturing Sales Value Share by Region (2021-2026) Table 33. Global Contract Pharmaceutical Manufacturing Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Contract Pharmaceutical Manufacturing Sales Value Share by Region (2027-2032) Table 35. Global Contract Pharmaceutical Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Contract Pharmaceutical Manufacturing Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Contract Pharmaceutical Manufacturing Sales Value Market Share by Country (2021-2026) Table 38. Global Contract Pharmaceutical Manufacturing Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Contract Pharmaceutical Manufacturing Sales Value Market Share by Country (2027-2032) Table 40. Catalent Company Information Table 41. Catalent Business Overview Table 42. Catalent Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Catalent Contract Pharmaceutical Manufacturing Product Portfolio Table 44. Catalent Recent Development Table 45. DPx Company Information Table 46. DPx Business Overview Table 47. DPx Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. DPx Contract Pharmaceutical Manufacturing Product Portfolio Table 49. DPx Recent Development Table 50. Lonza Company Information Table 51. Lonza Business Overview Table 52. Lonza Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Lonza Contract Pharmaceutical Manufacturing Product Portfolio Table 54. Lonza Recent Development Table 55. Piramal Healthcare Company Information Table 56. Piramal Healthcare Business Overview Table 57. Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Piramal Healthcare Contract Pharmaceutical Manufacturing Product Portfolio Table 59. Piramal Healthcare Recent Development Table 60. Aenova Company Information Table 61. Aenova Business Overview Table 62. Aenova Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Aenova Contract Pharmaceutical Manufacturing Product Portfolio Table 64. Aenova Recent Development Table 65. Jubilant Company Information Table 66. Jubilant Business Overview Table 67. Jubilant Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Jubilant Contract Pharmaceutical Manufacturing Product Portfolio Table 69. Jubilant Recent Development Table 70. Famar Company Information Table 71. Famar Business Overview Table 72. Famar Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Famar Contract Pharmaceutical Manufacturing Product Portfolio Table 74. Famar Recent Development Table 75. Boehringer Ingelheim Company Information Table 76. Boehringer Ingelheim Business Overview Table 77. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Portfolio Table 79. Boehringer Ingelheim Recent Development Table 80. Fareva Holding Company Information Table 81. Fareva Holding Business Overview Table 82. Fareva Holding Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Fareva Holding Contract Pharmaceutical Manufacturing Product Portfolio Table 84. Fareva Holding Recent Development Table 85. AbbVie Company Information Table 86. AbbVie Business Overview Table 87. AbbVie Contract Pharmaceutical Manufacturing Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. AbbVie Contract Pharmaceutical Manufacturing Product Portfolio Table 89. AbbVie Recent Development Table 90. Nipro Corp Company Information Table 91. Nipro Corp Business Overview Table 92. Nipro Corp Contract Pharmaceutical Manufacturing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Nipro Corp Contract Pharmaceutical Manufacturing Product Portfolio Table 94. Nipro Corp Recent Development Table 95. Vetter Company Information Table 96. Vetter Business Overview Table 97. Vetter Contract Pharmaceutical Manufacturing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Vetter Contract Pharmaceutical Manufacturing Product Portfolio Table 99. Vetter Recent Development Table 100. Sopharma Company Information Table 101. Sopharma Business Overview Table 102. Sopharma Contract Pharmaceutical Manufacturing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Sopharma Contract Pharmaceutical Manufacturing Product Portfolio Table 104. Sopharma Recent Development Table 105. DPT Laboratories Company Information Table 106. DPT Laboratories Business Overview Table 107. DPT Laboratories Contract Pharmaceutical Manufacturing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. DPT Laboratories Contract Pharmaceutical Manufacturing Product Portfolio Table 109. DPT Laboratories Recent Development Table 110. Recipharm Company Information Table 111. Recipharm Business Overview Table 112. Recipharm Contract Pharmaceutical Manufacturing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. Recipharm Contract Pharmaceutical Manufacturing Product Portfolio Table 114. Recipharm Recent Development Table 115. NextPharma Company Information Table 116. NextPharma Business Overview Table 117. NextPharma Contract Pharmaceutical Manufacturing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. NextPharma Contract Pharmaceutical Manufacturing Product Portfolio Table 119. NextPharma Recent Development Table 120. Dishman Company Information Table 121. Dishman Business Overview Table 122. Dishman Contract Pharmaceutical Manufacturing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. Dishman Contract Pharmaceutical Manufacturing Product Portfolio Table 124. Dishman Recent Development Table 125. Aesica Company Information Table 126. Aesica Business Overview Table 127. Aesica Contract Pharmaceutical Manufacturing Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. Aesica Contract Pharmaceutical Manufacturing Product Portfolio Table 129. Aesica Recent Development Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Contract Pharmaceutical Manufacturing Product Image Figure 2. Global Contract Pharmaceutical Manufacturing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 4. Global Contract Pharmaceutical Manufacturing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Oral Image Figure 8. Injectable Image Figure 9. API Image Figure 10. Other Image Figure 11. Global Contract Pharmaceutical Manufacturing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Contract Pharmaceutical Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Contract Pharmaceutical Manufacturing Sales Value Share by Type (2021-2032) Figure 14. Large Enterprise Image Figure 15. Small Medium Enterprise Image Figure 16. Global Contract Pharmaceutical Manufacturing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Contract Pharmaceutical Manufacturing Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Contract Pharmaceutical Manufacturing Sales Value Share by Application (2021-2032) Figure 19. Global Contract Pharmaceutical Manufacturing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Contract Pharmaceutical Manufacturing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Contract Pharmaceutical Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 22. North America Contract Pharmaceutical Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Contract Pharmaceutical Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Contract Pharmaceutical Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Contract Pharmaceutical Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Contract Pharmaceutical Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Contract Pharmaceutical Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 28. South America Contract Pharmaceutical Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Contract Pharmaceutical Manufacturing Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Contract Pharmaceutical Manufacturing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injectable
  • API
  • Other
Applications
  • Large Enterprise
  • Small Medium Enterprise
Companies covered
  • Catalent
  • DPx
  • Lonza
  • Piramal Healthcare
  • Aenova
  • Jubilant
  • Famar
  • Boehringer Ingelheim
  • Fareva Holding
  • AbbVie
  • Nipro Corp
  • Vetter
  • Sopharma
  • DPT Laboratories
  • Recipharm
  • NextPharma
  • Dishman
  • Aesica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Contract Pharmaceutical Manufacturing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Contract Pharmaceutical Manufacturing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Contract Pharmaceutical Manufacturing Market Dynamics
  1. 2.1 Contract Pharmaceutical Manufacturing Industry Trends
  2. 2.2 Contract Pharmaceutical Manufacturing Industry Drivers
  3. 2.3 Contract Pharmaceutical Manufacturing Industry Opportunities and Challenges
  4. 2.4 Contract Pharmaceutical Manufacturing Industry Restraints
3 Contract Pharmaceutical Manufacturing Market by Company
  1. 3.1 Global Contract Pharmaceutical Manufacturing Company Revenue Ranking in 2025
  2. 3.2 Global Contract Pharmaceutical Manufacturing Revenue by Company (2021-2026)
  3. 3.3 Global Contract Pharmaceutical Manufacturing Company Ranking (2024-2026)
  4. 3.4 Global Contract Pharmaceutical Manufacturing Company Manufacturing Base and Headquarters
  5. 3.5 Global Contract Pharmaceutical Manufacturing Company Product Type and Application
  6. 3.6 Global Contract Pharmaceutical Manufacturing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Contract Pharmaceutical Manufacturing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Contract Pharmaceutical Manufacturing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Contract Pharmaceutical Manufacturing Market by Type
  1. 4.1 Contract Pharmaceutical Manufacturing Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injectable
  4. 4.1.3 API
  5. 4.1.4 Other
  6. 4.2 Global Contract Pharmaceutical Manufacturing Sales Value by Type
  7. 4.2.1 Global Contract Pharmaceutical Manufacturing Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Contract Pharmaceutical Manufacturing Sales Value by Type (2021-2032)
  9. 4.2.3 Global Contract Pharmaceutical Manufacturing Sales Value Share by Type (2021-2032)
5 Contract Pharmaceutical Manufacturing Market by Application
  1. 5.1 Contract Pharmaceutical Manufacturing Application Introduction
  2. 5.1.1 Large Enterprise
  3. 5.1.2 Small Medium Enterprise
  4. 5.2 Global Contract Pharmaceutical Manufacturing Sales Value by Application
  5. 5.2.1 Global Contract Pharmaceutical Manufacturing Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Contract Pharmaceutical Manufacturing Sales Value by Application (2021-2032)
  7. 5.2.3 Global Contract Pharmaceutical Manufacturing Sales Value Share by Application (2021-2032)
6 Contract Pharmaceutical Manufacturing Regional Value Analysis
  1. 6.1 Global Contract Pharmaceutical Manufacturing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Contract Pharmaceutical Manufacturing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Contract Pharmaceutical Manufacturing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Contract Pharmaceutical Manufacturing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Contract Pharmaceutical Manufacturing Sales Value (2021-2032)
  7. 6.3.2 North America Contract Pharmaceutical Manufacturing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Contract Pharmaceutical Manufacturing Sales Value (2021-2032)
  10. 6.4.2 Europe Contract Pharmaceutical Manufacturing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Contract Pharmaceutical Manufacturing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Contract Pharmaceutical Manufacturing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Contract Pharmaceutical Manufacturing Sales Value (2021-2032)
  16. 6.6.2 South America Contract Pharmaceutical Manufacturing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Contract Pharmaceutical Manufacturing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Contract Pharmaceutical Manufacturing Sales Value Share by Country, 2025 VS 2032
7 Contract Pharmaceutical Manufacturing Country-level Value Analysis
  1. 7.1 Global Contract Pharmaceutical Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Contract Pharmaceutical Manufacturing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Contract Pharmaceutical Manufacturing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Contract Pharmaceutical Manufacturing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Contract Pharmaceutical Manufacturing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Contract Pharmaceutical Manufacturing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Contract Pharmaceutical Manufacturing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Catalent
  2. 8.1.1 Catalent Company Information
  3. 8.1.2 Catalent Business Overview
  4. 8.1.3 Catalent Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Catalent Contract Pharmaceutical Manufacturing Product Portfolio
  6. 8.1.5 Catalent Recent Developments
  7. 8.2 DPx
  8. 8.2.1 DPx Company Information
  9. 8.2.2 DPx Business Overview
  10. 8.2.3 DPx Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 DPx Contract Pharmaceutical Manufacturing Product Portfolio
  12. 8.2.5 DPx Recent Developments
  13. 8.3 Lonza
  14. 8.3.1 Lonza Company Information
  15. 8.3.2 Lonza Business Overview
  16. 8.3.3 Lonza Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Lonza Contract Pharmaceutical Manufacturing Product Portfolio
  18. 8.3.5 Lonza Recent Developments
  19. 8.4 Piramal Healthcare
  20. 8.4.1 Piramal Healthcare Company Information
  21. 8.4.2 Piramal Healthcare Business Overview
  22. 8.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Product Portfolio
  24. 8.4.5 Piramal Healthcare Recent Developments
  25. 8.5 Aenova
  26. 8.5.1 Aenova Company Information
  27. 8.5.2 Aenova Business Overview
  28. 8.5.3 Aenova Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Aenova Contract Pharmaceutical Manufacturing Product Portfolio
  30. 8.5.5 Aenova Recent Developments
  31. 8.6 Jubilant
  32. 8.6.1 Jubilant Company Information
  33. 8.6.2 Jubilant Business Overview
  34. 8.6.3 Jubilant Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jubilant Contract Pharmaceutical Manufacturing Product Portfolio
  36. 8.6.5 Jubilant Recent Developments
  37. 8.7 Famar
  38. 8.7.1 Famar Company Information
  39. 8.7.2 Famar Business Overview
  40. 8.7.3 Famar Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Famar Contract Pharmaceutical Manufacturing Product Portfolio
  42. 8.7.5 Famar Recent Developments
  43. 8.8 Boehringer Ingelheim
  44. 8.8.1 Boehringer Ingelheim Company Information
  45. 8.8.2 Boehringer Ingelheim Business Overview
  46. 8.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Portfolio
  48. 8.8.5 Boehringer Ingelheim Recent Developments
  49. 8.9 Fareva Holding
  50. 8.9.1 Fareva Holding Company Information
  51. 8.9.2 Fareva Holding Business Overview
  52. 8.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Product Portfolio
  54. 8.9.5 Fareva Holding Recent Developments
  55. 8.10 AbbVie
  56. 8.10.1 AbbVie Company Information
  57. 8.10.2 AbbVie Business Overview
  58. 8.10.3 AbbVie Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AbbVie Contract Pharmaceutical Manufacturing Product Portfolio
  60. 8.10.5 AbbVie Recent Developments
  61. 8.11 Nipro Corp
  62. 8.11.1 Nipro Corp Company Information
  63. 8.11.2 Nipro Corp Business Overview
  64. 8.11.3 Nipro Corp Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nipro Corp Contract Pharmaceutical Manufacturing Product Portfolio
  66. 8.11.5 Nipro Corp Recent Developments
  67. 8.12 Vetter
  68. 8.12.1 Vetter Company Information
  69. 8.12.2 Vetter Business Overview
  70. 8.12.3 Vetter Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Vetter Contract Pharmaceutical Manufacturing Product Portfolio
  72. 8.12.5 Vetter Recent Developments
  73. 8.13 Sopharma
  74. 8.13.1 Sopharma Company Information
  75. 8.13.2 Sopharma Business Overview
  76. 8.13.3 Sopharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sopharma Contract Pharmaceutical Manufacturing Product Portfolio
  78. 8.13.5 Sopharma Recent Developments
  79. 8.14 DPT Laboratories
  80. 8.14.1 DPT Laboratories Company Information
  81. 8.14.2 DPT Laboratories Business Overview
  82. 8.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 DPT Laboratories Contract Pharmaceutical Manufacturing Product Portfolio
  84. 8.14.5 DPT Laboratories Recent Developments
  85. 8.15 Recipharm
  86. 8.15.1 Recipharm Company Information
  87. 8.15.2 Recipharm Business Overview
  88. 8.15.3 Recipharm Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Recipharm Contract Pharmaceutical Manufacturing Product Portfolio
  90. 8.15.5 Recipharm Recent Developments
  91. 8.16 NextPharma
  92. 8.16.1 NextPharma Company Information
  93. 8.16.2 NextPharma Business Overview
  94. 8.16.3 NextPharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 NextPharma Contract Pharmaceutical Manufacturing Product Portfolio
  96. 8.16.5 NextPharma Recent Developments
  97. 8.17 Dishman
  98. 8.17.1 Dishman Company Information
  99. 8.17.2 Dishman Business Overview
  100. 8.17.3 Dishman Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Dishman Contract Pharmaceutical Manufacturing Product Portfolio
  102. 8.17.5 Dishman Recent Developments
  103. 8.18 Aesica
  104. 8.18.1 Aesica Company Information
  105. 8.18.2 Aesica Business Overview
  106. 8.18.3 Aesica Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Aesica Contract Pharmaceutical Manufacturing Product Portfolio
  108. 8.18.5 Aesica Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst